Patients in Lahore’s Hepatitis Control Program Await Medicines Amid Supply Shortage

Introduction: Patients registered with the Hepatitis Control Program in Lahore, Pakistan, are facing a critical shortage of medicines needed to complete their treatment courses. This concerning situation has arisen due to the Health department’s failure to purchase medicines at the high rates set by suppliers. Patients are now waiting for the resumption of medicine supply, which is expected by October 15, according to Dr. Abid Ghauri, the manager of the Hepatitis Control Program.

Key Points:

The Hepatitis Control Program in Punjab, Pakistan, is grappling with a shortage of medicines, putting the lives of registered patients at risk. Clinics across Punjab are currently facing a scarcity of essential medications, leaving patients in a vulnerable position.
Pakistan has been dealing with a significant burden of Hepatitis B and C cases. Reports suggest that at least one person in every family in Pakistan is expected to be suffering from these viruses. The country ranks as the third-largest nation affected by Hepatitis C globally.
In 2015, Hepatitis-related deaths worldwide totalled 13.40 million, underscoring the seriousness of the issue. Shockingly, over 111 individuals in Pakistan succumb to Hepatitis B and C every day. The country currently has over 1.5 million people living with these diseases, with a considerable number of them unaware of their infection.
Lack of awareness and limited access to medical checkups, often due to economic and social barriers, contribute to the spread of Hepatitis B and C in Pakistan. Experts emphasize the urgent need for awareness campaigns and advocate for including information about these viruses in the educational curriculum.
Controlling the transmission of the virus is also crucial. Sterilizing instruments used in healthcare settings, barber shops, and dentists’ clinics is essential to prevent further infections. Untrained individuals conducting medical procedures, such as teeth and ear cleaning on the streets, contribute to the rapid spread of the virus.
Pakistan’s Hepatitis C epidemic is a significant global health concern. Out of the 71 million people worldwide suffering from Hepatitis C, approximately 10% are in Pakistan. This alarming prevalence results in an estimated 40,000 deaths annually in the country.

Conclusion: The shortage of medicines in Lahore’s Hepatitis Control Program clinics raises serious concerns for registered patients who require these medications to complete their treatment courses. Pakistan’s battle against Hepatitis B and C underscores the importance of increasing awareness, improving access to medical care, and implementing stringent measures to prevent the spread of these deadly viruses. Addressing these challenges is critical to reducing the burden of Hepatitis-related illnesses and fatalities in Pakistan.